NDC product

Budesonide Inhalation

NDC 0591-3767 · Actavis Pharma, Inc.

Key facts

Product NDC 0591-3767
Proprietary name Budesonide Inhalation
Labeler Actavis Pharma, Inc.
Marketing category ANDA
Application number ANDA078404
Marketing start Dec 17, 2015
Marketing end May 31, 2018
Listing certified through May 31, 2018

At a glance

  • 1–9 Package NDCs

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About National Drug Codes (NDC)

The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.

Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date:

Browse all National Drug Codes (NDC)